To the Editor: Several studies have documented the high incidence of adverse events arising during hospital admission. The potential for discontinuity of care and poor communication is significant when patients are admitted to and discharged from hospitals, hence the Australian Pharmaceutical Advisory Council (APAC) has established guidelines to ensure continuity in the quality use of medicines.1 A study reported in 2001 by Mant et al found very low compliance with a minimum dataset based on the APAC guidelines.2 These authors subsequently held workshops to identify problems, develop action plans and refine these strategies. However, the follow-up report, published recently in the Journal, reported little change in adherence to the minimum dataset.3
The full article is accessible to AMA members and paid subscribers. Login to read more or purchase a subscription now.
Please note: institutional and Research4Life access to the MJA is now provided through Wiley Online Library.
- 1. Australian Pharmaceutical Advisory Council. National guidelines to achieve the continuum of quality use of medicines between hospital and community. Canberra: Commonwealth of Australia, 1998.
- 2. Mant A, Rotem WC, Kehoe L, Kaye KI. Compliance with guidelines for continuity of care in therapeutics from hospital to community. Med J Aust 2001; 174: 277-280.
- 3. Mant A, Kehoe L, Cockayne NL, et al. A Quality Use of Medicines program for continuity of care in therapeutics from hospital to community. Med J Aust 2002; 177: 32-34. <MJA full text>
- 4. Jackson CL, de Jong IC. Clinicians and guidelines: leading a horse to water. Med J Aust 2001; 174: 267-268.
- 5. Cameron B. The impact of pharmacy discharge planning on continuity of care. Can J Hosp Pharm 1994; 47: 101-109.